Form 4: Orthofix Medical Inc. CLO Jorge Andres Cedron Reports Acquisition and Disposal of Common Stock and Stock Options

Jorge Andres Cedron, CLO of Orthofix Medical Inc., reports acquiring and disposing of common stock and stock options on March 3, 2025.

Summary

• On March 3, 2025, Jorge Andres Cedron, the Chief Legal Officer (CLO) of Orthofix Medical Inc., filed a Form 4.
• The report details changes in beneficial ownership of Orthofix Medical Inc. securities.
• Cedron acquired 17,668 shares of common stock and disposed of some shares, resulting in a total of 46,316 shares beneficially owned following the transaction.
• Cedron also acquired 41,908 employee stock options with an exercise price of $16.98, exercisable in thirds on the first, second, and third anniversaries of the grant date, and disposed of some options.
• The options expire on March 3, 2032.
• The restricted stock units vest in thirds on the first, second, and third anniversaries of the grant date.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The restricted stock units and stock options vest over a three-year period from the grant date.

Industry Context

Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their trading activities and holdings in their own company's stock.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the transactions of company insiders.
• It helps stakeholders understand the alignment of management's interests with those of the shareholders.

Key Dates